Nilsine Partners LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Nilsine Partners LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,855 shares of the healthcare conglomerate’s stock after purchasing an additional 93 shares during the period. Nilsine Partners LLC’s holdings in UnitedHealth Group were worth $3,468,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Delta Financial Group Inc. grew its stake in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares in the last quarter. First PREMIER Bank boosted its holdings in shares of UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 18 shares during the period. Genesee Capital Advisors LLC raised its holdings in UnitedHealth Group by 1.9% during the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after buying an additional 18 shares during the period. Jmac Enterprises LLC boosted its stake in UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after buying an additional 18 shares during the period. Finally, Powers Advisory Group LLC grew its holdings in UnitedHealth Group by 4.8% during the 3rd quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock valued at $244,000 after purchasing an additional 19 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $543.41 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $500.09 billion, a P/E ratio of 35.06, a PEG ratio of 1.41 and a beta of 0.62. The company has a 50 day moving average price of $541.04 and a 200 day moving average price of $564.79.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. Stephens upped their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Barclays cut their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.